illumina is loosing its all time illumination.illumina is loosing its all time illumination. Looks like a change in fundamental business model is required to turn into market favorite
−7.34USD
−1.16 BUSD
4.50 BUSD
158.11 M
About Illumina, Inc.
Sector
Industry
CEO
Jacob Thaysen
Website
Headquarters
San Diego
Employees (FY)
12.01 K
Founded
1998
ISIN
US4523271090
FIGI
BBG000DSMS70
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ILMN is featured.
Frequently Asked Questions
The current price of ILMN is 121.16 USD — it has decreased by 4.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Illumina, Inc. stocks are traded under the ticker ILMN.
Illumina, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Illumina, Inc. has a max estimate of 253.00 USD and a min estimate of 100.00 USD.
ILMN earnings for the last quarter are 0.33 USD whereas the estimation was 0.15 USD which accounts for 121.28% surprise. Estimated earnings for the next quarter are 0.02 USD. See more details about Illumina, Inc. earnings.
Illumina, Inc. revenue for the last quarter amounts to 1.12 B USD despite the estimated figure of 1.13 B USD. In the next quarter revenue is expected to reach 1.09 B USD.
Yes, you can track Illumina, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ILMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Illumina, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 12.01 K employees. See our rating of the largest employees — is Illumina, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Illumina, Inc. EBITDA is 357.00 M USD, and current EBITDA margin is 7.50%. See more stats in Illumina, Inc. financial statements.